Australia markets open in 5 hours 11 minutes

Hubei Biocause Pharmaceutical Co., Ltd. (000627.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
1.8500+0.0100 (+0.54%)
At close: 03:04PM CST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-786,840
-651,759
274,051
470,714
580,292
-
Depreciation & amortisation
-
152,373
147,270
133,936
63,662
-
Change in working capital
-
14,611,572
16,073,051
11,933,521
30,709,319
-
Inventory
-
-2,124,763
-279,554
471,058
-188,321
-
Other working capital
-19,566,439
9,466,713
7,389,137
3,885,475
21,112,676
-
Other non-cash items
-
791,555
624,880
514,999
193,243
-
Net cash provided by operating activities
-
9,534,242
7,524,197
4,172,608
21,421,088
-
Cash flows from investing activities
Investments in property, plant and equipment
-64,582
-67,529
-135,061
-287,133
-308,412
-
Acquisitions, net
-
-
-
-
-3,440,476
-
Purchases of investments
-156,095,865
-161,933,574
-97,626,836
-109,755,016
-71,494,590
-
Sales/maturities of investments
169,455,917
158,523,858
84,126,123
94,717,729
67,783,496
-
Other investing activities
-264,331
-166,789
-1,996,409
-62,202
-223,771
-
Net cash used for investing activities
13,032,804
-3,642,412
-15,615,009
-15,384,837
-7,682,173
-
Net change in cash
-10,590,547
1,836,053
3,059,027
-3,606,853
13,877,600
-
Cash at beginning of period
31,777,127
26,309,323
23,250,296
26,857,149
12,979,549
-
Cash at end of period
21,160,822
28,145,377
26,309,323
23,250,296
26,857,149
-
Free cash flow
Operating cash flow
-
9,534,242
7,524,197
4,172,608
21,421,088
-
Capital expenditure
-64,582
-67,529
-135,061
-287,133
-308,412
-
Free cash flow
-19,566,439
9,466,713
7,389,137
3,885,475
21,112,676
-